MetLife Investment Management’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.74M | Buy |
13,468
+142
| +1% | +$20.4K | 0.01% | 1130 |
|
|
2025
Q4 | $1.9M | Sell |
13,326
-103,254
| -89% | -$13.8M | 0.01% | 1097 |
|
|
2025
Q3 | $14M | Sell |
116,580
-20,903
| -15% | -$2.65M | 0.07% | 272 |
|
|
2025
Q2 | $18.2M | Buy |
137,483
+14,442
| +12% | +$1.96M | 0.11% | 172 |
|
|
2025
Q1 | $17.1M | Buy |
123,041
+110,095
| +850% | +$17.1M | 0.09% | 188 |
|
|
2024
Q4 | $2.01M | Buy |
12,946
+557
| +4% | +$94.2K | 0.01% | 1037 |
|
|
2024
Q3 | $2.26M | Buy |
12,389
+6,981
| +129% | +$1.03M | 0.01% | 953 |
|
|
2024
Q2 | $642K | Buy |
5,408
+5,014
| +1,273% | +$528K | ﹤0.01% | 1587 |
|
|
2024
Q1 | $42.3K | Buy |
394
+1
| +0.3% | +$99 | ﹤0.01% | 2730 |
|
|
2023
Q4 | $39.2K | Sell |
393
-11,225
| -97% | -$1.1M | ﹤0.01% | 2786 |
|
|
2023
Q3 | $1.38M | Sell |
11,618
-496
| -4% | -$74K | 0.01% | 1069 |
|
|
2023
Q2 | $2.16M | Sell |
12,114
-390
| -3% | -$71.6K | 0.02% | 904 |
|
|
2023
Q1 | $2.06M | Sell |
12,504
-328
| -3% | -$56.4K | 0.01% | 901 |
|
|
2022
Q4 | $2.02M | Sell |
12,832
-219
| -2% | -$33.3K | 0.02% | 893 |
|
|
2022
Q3 | $1.97M | Sell |
13,051
-158
| -1% | -$26.3K | 0.02% | 884 |
|
|
2022
Q2 | $2.17M | Buy |
13,209
+313
| +2% | +$60.3K | 0.02% | 873 |
|
|
2022
Q1 | $2.87M | Buy |
12,896
+3,221
| +33% | +$722K | 0.02% | 840 |
|
|
2021
Q4 | $2.3M | Buy |
9,675
+98
| +1% | +$22.9K | 0.02% | 817 |
|
|
2021
Q3 | $2.24M | Sell |
9,577
-284
| -3% | -$59.6K | 0.02% | 810 |
|
|
2021
Q2 | $2.03M | Sell |
9,861
-294
| -3% | -$60.5K | 0.02% | 870 |
|
|
2021
Q1 | $2.09M | Sell |
10,155
-523
| -5% | -$110K | 0.02% | 854 |
|
|
2020
Q4 | $2.29M | Sell |
10,678
-471
| -4% | -$91.4K | 0.02% | 759 |
|
|
2020
Q3 | $2.04M | Sell |
11,149
-356
| -3% | -$67K | 0.02% | 713 |
|
|
2020
Q2 | $2.12M | Buy |
11,505
+469
| +4% | +$93.2K | 0.02% | 692 |
|
|
2020
Q1 | $2.23M | Hold |
11,036
| – | – | 0.03% | 564 |
|
|
2019
Q4 | $2.07M | Sell |
11,036
-143
| -1% | -$24.6K | 0.02% | 797 |
|
|
2019
Q3 | $1.78M | Buy |
11,179
+1,286
| +13% | +$256K | 0.02% | 831 |
|
|
2019
Q2 | $2.49M | Sell |
9,893
-228
| -2% | -$52.8K | 0.03% | 710 |
|
|
2019
Q1 | $2.42M | Buy |
10,121
+2
| +0% | +$480 | 0.03% | 730 |
|
|
2018
Q4 | $2.32M | Sell |
10,119
-31
| -0.3% | -$7.64K | 0.03% | 690 |
|
|
2018
Q3 | $2.87M | Buy |
10,150
+573
| +6% | +$168K | 0.03% | 694 |
|
|
2018
Q2 | $2.81M | Sell |
9,577
-6,620
| -41% | -$1.81M | 0.03% | 657 |
|
|
2018
Q1 | $4.09M | Buy |
16,197
+9,422
| +139% | +$2.21M | 0.05% | 422 |
|
|
2017
Q4 | $1.46M | Buy |
+6,775
| New | +$1.37M | 0.02% | 879 |
|
Other funds holding ICUI
VPM
VCM
RRAM
MetLife Investment Management's ICUI Position: Q1 2026 in Review
MetLife Investment Management increased its ICU Medical (ICUI) stake by 1.1% in Q1 2026, buying an estimated $20.4K and bringing the position to 13,468 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #1130.
MetLife Investment Management first reported a position in ICUI in Q4 2017 and has held it in 34 quarters since. The position peaked at $18.2M in Q2 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- MetLife Investment Management held 13,468 shares of ICU Medical worth $1.74M as of Q1 2026.
- MetLife Investment Management bought 142 ICU Medical shares in Q1 2026, an estimated $20.4K.
- ICU Medical made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1130 holding.
- MetLife Investment Management first reported a position in ICU Medical in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's ICU Medical position peaked at $18.2M in Q2 2025.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.